glp-1 dose titration guidelines clinical trials Focus on Agonists in Type 2 Diabetes Mellitus Discover How GLP-1 Trials Are

She did a follow up to ensure about the situation

Hair loss is a patient-valued outcome, lead researcher Yong Chen wrote, adding that it can affect self-esteem, quality of life, and adherence to treatment. For many, the benefits vastly outweigh the drawbacks, but researchers said the findings should help patients understand the potential trade-offs before startingor deciding whether to continuethe highly popular medication

10.1007/s12035-023-03604-4 125 IsmailH.ShakkourZ.TabetM.AbdelhadyS.KobaisiA.AbediR.et al (2020)

16 More recently, the FLOW trial enrolled 3,533 patients with T2D and CKD (estimated glomerular filtration rate [eGFR] 5075 ml/min/1.73 m 2 with an albumin-to-creatinine ratio of 3005,000 or eGFR 2549 ml/min/1.73 m 2 with an albumin-to-creatinine ratio of 1005,000)

Weekly Schedule Example Option A (standard): 1 mL once weekly 10 doses (10 weeks) Option B (enhanced): 1 mL twice weekly 10 doses (5 weeks) Option C (light): 0.5 mL once weekly 20 doses (20 weeks) 4

What is the plan for follow-up